ctDNA in the Management of Resectable & Advanced Colorectal Cancer: Current Status and Future Directions
Current professional guidance supports a cautious distinction between clinical validity and clinical utility: ctDNA can inform prognosis, counseling, and clinical-trial eligibility, but should not routinely replace standard surveillance or independently determine treatment escalation or de-escalation outside evidence-b...